Drug Development Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Drug Development stocks.

Drug Development Stocks Recent News

Date Stock Title
Jul 3 LDOS Zacks.com featured highlights include ResMed, Badger Meter, Leidos and Ingersoll Rand
Jul 3 LDOS Zacks.com featured highlights include Tenet Healthcare, Leidos Holdings, Atmos Energy and Cabot
Jul 3 CDXS Beacon raises $170M for eye gene therapy; J&J confirms Carvykti survival benefit
Jul 2 LDOS 4 Top Earnings Growth Stocks to Buy: RMD, BMI, LDOS, IR
Jul 2 LDOS 4 Stocks That Boast Remarkable Interest Coverage Ratio
Jul 2 LDOS Zacks.com featured highlights include Leidos, Cabot, Williams-Sonoma, Booz Allen Hamilton and Brady
Jul 2 LDOS Defense Contractors Stocks Q1 Recap: Benchmarking Leidos (NYSE:LDOS)
Jul 1 CDXS Codexis to sell Pompe, Fabry assets to Crosswalk Therapeutics
Jul 1 CDXS Codexis Finalizes Purchase Agreement with Crosswalk Therapeutics for Gene Therapy Assets
Jul 1 LDOS Zacks.com featured highlights include Amkor Technology, Tenet Healthcare, Leidos and Maximus
Jul 1 LDOS 5 Dividend Stocks to Pick for Solid Growth in the Second Half
Jul 1 NMRA 10 clinical trials to watch in the second half of 2024
Jun 28 ALMS Alumis, in trading debut, falls 22% from IPO price
Jun 28 LDOS Leidos and America's Car-Mart have been highlighted as Zacks Bull and Bear of the Day
Jun 28 LDOS 4 Stocks Trading Near 52-Week High That Can Climb Further
Jun 28 MNMD Mind Medicine to join Russell 2000 index
Jun 28 MNMD MindMed to be Included in Russell 2000® and Russell 3000® Indexes
Jun 28 ALMS Alumis prices IPO at $16 per share
Jun 28 ALMS Alumis Announces Pricing of Initial Public Offering
Jun 27 LDOS NASA awards Leidos with $476.5M cargo mission support contract
Drug Development

Drug development is the process of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery. It includes pre-clinical research on microorganisms and animals, filing for regulatory status, such as via the United States Food and Drug Administration for an investigational new drug to initiate clinical trials on humans, and may include the step of obtaining regulatory approval with a new drug application to market the drug.

Browse All Tags